CHDI Foundation
The CHDI Foundation, Inc., is a United States–based non-profit biomedical foundation that aims to "rapidly discover and develop drugs that delay or slow the progression of Huntington's disease", a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CHDI Foundation, United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
61%
Total
Publications
574
Total Open
Publications
353
Total
Citations
27K
Open Access
Percentage
61%
Total
Publications
574
Total Open
Publications
353
Total
Citations
27K
Breakdown
Publisher Open
9%
Both
32%
Other Platform Open
21%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 44%
103
Hybrid 38%
88
No Guarantees 18%
42
Other Platform Open
Domain 80%
243
Institution 40%
121
Preprint 16%
48
Public 12%
35
Other Internet 11%
34
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 241 |
Europe PMC | Domain | 147 |
University College London - UCL Discovery | Institution | 83 |
bioRxiv | Preprint | 32 |
Semantic Scholar | Public | 29 |
Cardiff University - ORCA Online Research @Cardiff | Institution | 27 |
DOI | Other Internet | 21 |
University of Antwerp - Institutional Repository University of Antwerp | Institution | 20 |
Monash University - Monash University Research Portal | Institution | 9 |
The University of Glasgow - Enlighten: Publications | Institution | 8 |